SARS_CoV_2 Infection Clinical Trials in Tomball

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults
Active, not recruiting
  • SARS-CoV-2 Infection
  • Intramuscular injection
  • Intramuscular vaccine
  • Birmingham, Alabama
  • +90 more
2022-04-04
Apr 4, 2022
B
To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age.
Recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • +4 more
  • Athens, Alabama
  • +152 more
2022-03-29
Mar 29, 2022
B
Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals
Recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b1
  • +3 more
  • Athens, Alabama
  • +165 more
2022-03-25
Mar 25, 2022
P
Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2 - 2021
Completed
  • Pneumococcal Disease
  • +2 more
  • 20-valent pneumococcal conjugate vaccine (20vPnC)
  • +2 more
  • Anaheim, California
  • +28 more
2022-03-23
Mar 23, 2022
B
A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants - 2021
Completed
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • BNT162b2.B.1.351
  • Oakland, California
  • +16 more
2022-02-17
Feb 17, 2022
B
A Study to Evaluate Safety, Tolerability, & Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults - 2021
Completed
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • Anaheim, California
  • +20 more
2022-02-17
Feb 17, 2022